Category CORONAVIRUS CHINA

PIER MARIA FORNASARI
2020-11-09

SARS-CoV-2 mink-associated variant strain in Denmark. For WHO other five countries, the Netherlands, Spain, Sweden, Italy and the USA have reported SARS-CoV-2 in farmed minks.

Since June 2020, 214 human cases of COVID-19 have been identified in Denmark with SARS-CoV-2 variants associated with farmed minks, including 12 cases with a unique variant, reported on 5 November. All 12 cases were identified in September 2020 in North Jutland, Denmark. The cases ranged in age from 7 to 79 years, and eight

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-31

China to include symptom-free coronavirus carriers in national figures

The national health commission said it would start to include asymptomatic cases in its Covid-19 statistics in move to address public concern Classified government data has suggested that silent carriers could make up around a third of cases Source South China Morning Post China will include asymptomatic coronavirus carriers in its daily figures from Wednesday,

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-17

Researchers working at the drug centre for Covid-19 cure at a company in Wuqing District report new progress in drug, therapies against Covid-19

China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the Covid-19 (coronavirus) outbreak, according to an official today Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-10

Mesoblast To Evaluate Anti-Inflammatory Cell Therapy Remestemcel-L For Treatment Of COVID-19 Lung Disease

Mesoblast today announced that it plans to evaluate its allogeneic mesenchymal stem cell (MSC) product candidate remestemcel-L in patients with acute respiratory distress syndrome (ARDS) caused by coronavirus (COVID-19) in the United States, Australia, China and Europe.  The Company is in active discussions with various government and regulatory authorities, medical institutions and pharmaceutical companies to

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-10

New Study on COVID-19 Estimates 5.1 Days for Incubation Period Supporting Current 14-Days Quarantine Period

An analysis of publicly available data on infections from the new coronavirus, SARS-CoV-2, that causes the respiratory illness COVID-19 yielded an estimate of 5.1 days for the median disease incubation period, according to a new study led by researchers at Johns Hopkins Bloomberg School of Public Health. This median time from exposure to onset of

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-10

People who contract the Covid-19 emit high amounts of virus very early in their infection, according to a new study from Germany

This helps to explain the rapid and efficient way in which the virus has spread around the world. At the same time, the study suggests that while people with mild infections can still test positive by throat swabs for days and even weeks after their illness, those who are only mildly sick are likely not still infectious

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-07

Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China

The epidemiological features of the coronavirus disease 2019 (Covid-19) outbreak are described and evaluated the impact of non-pharmaceutical interventions on the epidemic in Wuhan, China. Individual-level data on 25,961 laboratory-confirmed Covid-19 cases reported through February 18, 2020 were extracted from the municipal Notifiable Disease Report System. Based on key events and interventions, the epidemic was

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-06

Takeda Pharma is developing Covid-19 recovered patients plasma-based immunoglobulins drug

Takeda Pharmaceutical Co said on Wednesday it was developing a drug for high-risk patients infected with the new coronavirus, joining several other drugmakers seeking to develop a treatment for an illness that has killed over 3,000 people. The Japanese firm said it was working on a plasma-derived therapy which had previously been shown to be

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-03-06

First Covid-19 vaccine trial in the US is recruiting volunteers

Forty-five people will be enrolled in the preliminary safety trial of the new vaccine. Researchers in Seattle have begun recruiting healthy volunteers to participate in a clinical trial for an experimental COVID-19 vaccine, according to news reports. The vaccine, developed by the biotechnology company Moderna Therapeutics, was initially sent to the National Institute of Allergy

Read More

No Comments InCORONAVIRUS CHINA